Huiyu Pharmaceutical (688553.SH) two subsidiaries received multiple overseas drug listing licenses.

Huayu Pharmaceuticals (688553.SH) announced that its subsidiaries Seacross Pharma (Europe) Ltd. and Seacross Pharmaceuticals Ltd. have recently received marketing approvals for the company's products including injection sodium mebucainide, injection cetirizine, injection cyclophosphamide, and injection parecetamol sodium from the Drug Regulatory Authority of Turkmenistan, the Spanish Agency for Medicines and Medical Devices, the Italian Ministry of Health, and the UK Medicines and Healthcare Products Regulatory Agency respectively.